Detalhe da pesquisa
1.
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia.
Blood
; 137(14): 1879-1894, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150388
2.
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Hematol Oncol
; 39(4): 529-538, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405901
3.
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
Cancer
; 125(16): 2810-2817, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012967
4.
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Eur J Haematol
; 102(1): 79-86, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267597
5.
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia.
Haematologica
; 105(6): e294-e297, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537688
6.
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.
Clin Lymphoma Myeloma Leuk
; 21(10): e801-e809, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376375
7.
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL).
Leuk Res
; 109: 106612, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34139642
8.
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols.
Hemasphere
; 7(1): e810, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583094